{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:54Z","timestamp":1786119354560,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1097\/wad.0b013e3181b7642b","type":"journal-article","created":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T05:32:39Z","timestamp":1274851959000},"page":"209-211","source":"Crossref","is-referenced-by-count":22,"title":["Donepezil-associated Bradyarrhythmia in a Patient With Dementia With Lewy Bodies (DLB)"],"prefix":"10.1097","volume":"24","author":[{"given":"Michael H.","family":"Rosenbloom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Finley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin M.","family":"Scheinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell D.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil D.","family":"Rabinovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210128","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"R2-17-20210128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1176\/jnp.16.4.409","article-title":"The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies","volume":"16","author":"Simard","year":"2004","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R3-17-20210128","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/gps.1381","article-title":"A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies","volume":"20","author":"Thomas","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"R4-17-20210128","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/jnnp.70.6.781","article-title":"Cardiac (123)I\u2013meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease","volume":"70","author":"Watanabe","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5-17-20210128","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.expneurol.2004.05.002","article-title":"Cholinesterase inhibitors modify the activity of intrinsic cardiac neurons","volume":"188","author":"Darvesh","year":"2004","journal-title":"Exp Neurol"},{"key":"R6-17-20210128","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1345\/aph.18273","article-title":"Donepezil overdose: a tenfold dosing error","volume":"33","author":"Shepherd","year":"1999","journal-title":"Ann Pharmacother"},{"key":"R7-17-20210128","first-page":"1070","article-title":"Symptomatic sinus bradycardia associated with donepezil","volume":"28","author":"Calvo-Romero","year":"1999","journal-title":"Rev Neurol"},{"key":"R8-17-20210128","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/emj.2006.036251","article-title":"Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil","volume":"23","author":"Suleyman","year":"2006","journal-title":"Emerg Med J"},{"key":"R9-17-20210128","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1099-5129(03)00080-1","article-title":"Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors","volume":"5","author":"Bordier","year":"2003","journal-title":"Europace"},{"key":"R10-17-20210128","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1368-5031.2006.00967.x","article-title":"Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias","volume":"60","author":"Ballard","year":"2006","journal-title":"Int J Clin Pract"}],"container-title":["Alzheimer Disease & Associated Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WAD.0b013e3181b7642b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:21:03Z","timestamp":1786040463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002093-201004000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wad.0b013e3181b7642b","relation":{},"ISSN":["0893-0341"],"issn-type":[{"value":"0893-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}